19990203
 Incyte's Earnings Fall On Costs, but Shares Leap 23% Amid Deal   The Wall Street Journal,  Feb 4, 1999  PALO ALTO, Calif. -- Incyte Pharmaceuticals Inc. said genetic-code deciphering and other discovery programs lowered fourth-quarter profit and will trigger a 1999 loss. But the company also altered its financing plan for a genetics unit and unveiled an expanded partnership with Johnson & Johnson, pushing its stock up 23%.   
